Miller Sheldon L 4

4 · SPECTRASCIENCE INC · Filed Jun 29, 2010

Form 4

Period: 2010-06-18

Director

Transactions

Purchase
Series C Preferred Stock
2010-06-18+1,970,000→ 1,970,000 total
Exercise: $0.20From: 2010-06-18→ Common Stock (1,970,000 underlying)
Purchase
Common Stock Warrants (right to buy)
2010-06-18+985,000→ 985,000 total
Exercise: $0.30From: 2010-06-18Exp: 2015-06-18→ Common Stock (985,000 underlying)
Purchase
Common Stock Warrants (right to buy)
2010-06-18+523,078→ 523,078 total(indirect: By LLC)
Exercise: $0.30From: 2010-06-18Exp: 2015-06-18→ Common Stock (523,078 underlying)
Purchase
Series C Preferred Stock
2010-06-18+1,046,155→ 1,046,155 total(indirect: By LLC)
Exercise: $0.20From: 2010-06-18→ Common Stock (1,046,155 underlying)

Holdings

Stock Option (right to buy)
Exercise: $0.24Exp: 2020-05-21→ Common Stock (400,000 underlying)
400,000

Footnotes (5)

[F1]133,333 shares vest on each of 5/21/11 and 5/21/12; 133,334 shares vest on 5/21/13.
[F2]The Series C stock has no expiration date.
[F3]The reported securities are included within 39,400 Issuer Units purchased by the reporting person for $10 per Unit. Each Unit consists of 50 shares of the Issuer's Series C preferred stock and 25 five-year cashless warrants to purchase common stock.
[F4]The reported securities are included within 29,923.1 Issuer Units purchased by the reporting person for $10 per Unit. Each Unit consists of 50 shares of the Issuer's Series C preferred stock and 25 five-year cashless warrants to purchase common stock.
[F5]The reporting person has 100% control over the LLC that owns the reported securities.

Documents

1 file